Clinical Trial Update: ITACA-S2 (Intergroup Trial in Adjuvant Chemotherapy for Adenocarcinoma of the Stomach) [Phase 3]

View source ↗

Summary

The ITACA-S2 Phase 3 trial evaluating adjuvant chemotherapy for gastric adenocarcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Gastric Adenocarcinoma | Phase 3 | Status: TERMINATED